List of combined sex-hormonal preparations

This is a list of known combined sex-hormonal formulations. Brand names and developmental code names are in parentheses.

Androgens

Marketed

Marketed

Estrogens

Marketed

Marketed

Never marketed

Progestogens

Marketed

Androgens and estrogens

Marketed
  • Chlorotrianisene/methyltestosterone (Tace mit Androgen)[1]
  • Conjugated estrogens/methyltestosterone (Premarin with Methyltestosterone)
  • Dienestrol/methyltestosterone (Estan, Lucidon)
  • Dienestrol diacetate/methyltestosterone (Farmatest)
  • Diethylstilbestrol/methyltestosterone (Tylosterone)
  • Esterified estrogens/methyltestosterone (Covaryx, Eemt, Essian, Estratest, Menogen, Syntest)
  • Ethinylestradiol/methyltestosterone (Climatone, Dumone, Duotrone, Estandron, Femandren, Femovirin, Gynetone, Lynandron, Mepilin, Mixogen, Primodian)[1][2]
  • Methylestradiol/methyltestosterone (Klimanosid)[2]
  • Methylestradiol/methyltestosterone/reserpine (Klimanosid R)[1]

Marketed

Marketed
  • Diethylstilbestrol/methyltestosterone (Maxymin, Tylosterone)
  • Diethylstilbestrol/testosterone (Rapigain)
  • Estradiol benzoate/estradiol enanthate/testosterone enanthate (Uni-Bol)
  • Estradiol benzoate/testosterone propionate (Component E-H, Implix BF, Progro H, Synovex H)
  • Ethinylestradiol/methyltestosterone (Taril)

Estrogens and progestogens

Marketed

In birth control pills:

For menopausal hormone therapy and/or gynecological disorders:

Never or not yet marketed

In birth control pills:

Marketed

In contraceptive patches:

For menopausal hormone therapy:

Marketed

In contraceptive vaginal rings:

Marketed

In combined injectable contraceptives:

For menopausal hormone therapy, gynecological disorders, habitual abortion, and other indications:

Never marketed

In combined injectable contraceptives:

For other indications:

Marketed

Androgens and progestogens

Marketed
  • Methyltestosterone/ethisterone (Androgeston)[1]

Marketed

Marketed
  • Danazol/megestrol acetate (Dogalact)
  • Nandrolone decanoate/methandriol dipropionate (Filybol, Tribolin)
  • Nandrolone phenylpropionate/methandriol dipropionate (RWR)

Estrogens, progestogens, and androgens

Marketed
  • Methylestradiol/normethandrone (Ginecosid, Ginecoside, Mediol, Renodiol)

Not yet marketed

Marketed
  • Estradiol/progesterone/methyltestosterone (Trihormonal)[1]
  • Ethinylestradiol/ethisterone/methyltestosterone (Trinestryl, Trimone Sublets)[1]

Marketed

Never marketed

Marketed
  • Estradiol/trenbolone acetate (Component, Compudose-G, Progro TE-H, Revalor, Synovex)
  • Estradiol benzoate/trenbolone acetate (Synovex Choice, Synovex One, Synovex Plus, Synovex with Trenbolone Acetate)

Miscellaneous

Marketed

Marketed
  • Estradiol benzoate/prednisolone/salicylic acid (Alpicort E, Alpicort F, Alpicort Plus)

Marketed
  • Estradiol benzoate/gentamicin/hydrocortisone/nystatin (Cridermol Fem, Ginabiot, Ginecovan)
  • Estradiol benzoate/monalazone (Malun-25)

Marketed
  • Goserelin/bicalutamide (ZolaCos CP)
  • Leuprorelin/norethisterone acetate (Lupaneta Pack)

See also

References
  1. Hans Hermann Julius Hager; Walther Kern; Paul Heinz List; Hermann Josef Roth (29 July 2013). Hagers Handbuch der Pharmazeutischen Praxis: Für Apotheker, Arzneimittelhersteller, Ärzte und Medizinalbeamte: Wirkstoffgruppen II Chemikalien und Drogen (A-AL). Springer-Verlag. pp. 143, 185–187. ISBN 978-3-662-25655-8.
  2. Georg Arends; Heinrich Zörnig; Hermann Hager; Georg Frerichs, Walther Kern (14 December 2013). Hagers Handbuch der pharmazeutischen Praxis: Für Apotheker, Arzneimittelhersteller, Drogisten, Ärzte u. Medizinalbeamte. Springer-Verlag. pp. 1163–1164. ISBN 978-3-662-36329-4.
  3. Josef Kimmig (14 March 2013). Therapie der Haut- und Geschlechtskrankheiten. Springer-Verlag. pp. 508–. ISBN 978-3-642-94850-3.
  4. "Spezialitäten". Klinische Wochenschrift. 30 (15–16): 367. 1952. doi:10.1007/BF01472052. ISSN 0023-2173.
  5. https://www.jstage.jst.go.jp/article/sanpunosinpo1949/8/2/8_2_100/_pdf
  6. Hormone und Psyche die Endokrinologie des Alternden Menschen: Fünftes Symposion der Deutschen Gesellschaft für Endokrinologie Freiburg (Breisgau), den 7. bis 9. März 1957. Springer-Verlag. 9 March 2013. pp. 55–. ISBN 978-3-642-87014-9.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.